vs

Side-by-side financial comparison of FULTON FINANCIAL CORP (FULT) and Harmony Biosciences Holdings, Inc. (HRMY). Click either name above to swap in a different company.

FULTON FINANCIAL CORP is the larger business by last-quarter revenue ($336.2M vs $243.8M, roughly 1.4× Harmony Biosciences Holdings, Inc.). FULTON FINANCIAL CORP runs the higher net margin — 28.2% vs 9.2%, a 19.0% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs 4.2%). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs 0.2%).

Fulton Financial Corporation is an American regional financial services holding company, headquartered in Lancaster, Pennsylvania.

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

FULT vs HRMY — Head-to-Head

Bigger by revenue
FULT
FULT
1.4× larger
FULT
$336.2M
$243.8M
HRMY
Growing faster (revenue YoY)
HRMY
HRMY
+16.9% gap
HRMY
21.1%
4.2%
FULT
Higher net margin
FULT
FULT
19.0% more per $
FULT
28.2%
9.2%
HRMY
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
0.2%
FULT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FULT
FULT
HRMY
HRMY
Revenue
$336.2M
$243.8M
Net Profit
$94.8M
$22.5M
Gross Margin
71.9%
Operating Margin
15.8%
Net Margin
28.2%
9.2%
Revenue YoY
4.2%
21.1%
Net Profit YoY
1.9%
-54.6%
EPS (diluted)
$0.55
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FULT
FULT
HRMY
HRMY
Q1 26
$336.2M
Q4 25
$336.0M
$243.8M
Q3 25
$334.6M
$239.5M
Q2 25
$324.1M
$200.5M
Q1 25
$318.4M
$184.7M
Q4 24
$319.6M
$201.3M
Q3 24
$317.7M
$186.0M
Q2 24
$334.7M
$172.8M
Net Profit
FULT
FULT
HRMY
HRMY
Q1 26
$94.8M
Q4 25
$99.0M
$22.5M
Q3 25
$100.5M
$50.9M
Q2 25
$99.2M
$39.8M
Q1 25
$93.0M
$45.6M
Q4 24
$68.6M
$49.5M
Q3 24
$63.2M
$46.1M
Q2 24
$95.0M
$11.6M
Gross Margin
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
71.9%
Q3 25
75.1%
Q2 25
81.0%
Q1 25
82.7%
Q4 24
73.0%
Q3 24
77.0%
Q2 24
81.4%
Operating Margin
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
35.7%
15.8%
Q3 25
38.2%
27.3%
Q2 25
37.8%
24.0%
Q1 25
36.1%
30.4%
Q4 24
27.0%
27.7%
Q3 24
25.1%
33.2%
Q2 24
30.8%
12.4%
Net Margin
FULT
FULT
HRMY
HRMY
Q1 26
28.2%
Q4 25
29.5%
9.2%
Q3 25
30.0%
21.2%
Q2 25
30.6%
19.8%
Q1 25
29.2%
24.7%
Q4 24
21.5%
24.6%
Q3 24
19.9%
24.8%
Q2 24
28.4%
6.7%
EPS (diluted)
FULT
FULT
HRMY
HRMY
Q1 26
$0.55
Q4 25
$0.53
$0.38
Q3 25
$0.53
$0.87
Q2 25
$0.53
$0.68
Q1 25
$0.49
$0.78
Q4 24
$0.36
$0.85
Q3 24
$0.33
$0.79
Q2 24
$0.52
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FULT
FULT
HRMY
HRMY
Cash + ST InvestmentsLiquidity on hand
$775.3M
Total DebtLower is stronger
$163.7M
Stockholders' EquityBook value
$3.5B
$870.2M
Total Assets
$32.2B
$1.3B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
$775.3M
Q3 25
$672.6M
Q2 25
$565.3M
Q1 25
$507.0M
Q4 24
$467.2M
Q3 24
$410.5M
Q2 24
$346.9M
Total Debt
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
$163.7M
Q3 25
$168.5M
Q2 25
$172.1M
Q1 25
$175.7M
Q4 24
$179.3M
Q3 24
$182.8M
Q2 24
$186.4M
Stockholders' Equity
FULT
FULT
HRMY
HRMY
Q1 26
$3.5B
Q4 25
$3.5B
$870.2M
Q3 25
$3.4B
$835.1M
Q2 25
$3.3B
$773.1M
Q1 25
$3.3B
$720.5M
Q4 24
$3.2B
$659.2M
Q3 24
$3.2B
$596.8M
Q2 24
$3.1B
$538.6M
Total Assets
FULT
FULT
HRMY
HRMY
Q1 26
$32.2B
Q4 25
$32.1B
$1.3B
Q3 25
$32.0B
$1.2B
Q2 25
$32.0B
$1.1B
Q1 25
$32.1B
$1.1B
Q4 24
$32.1B
$999.2M
Q3 24
$32.2B
$928.1M
Q2 24
$31.8B
$858.4M
Debt / Equity
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
0.19×
Q3 25
0.20×
Q2 25
0.22×
Q1 25
0.24×
Q4 24
0.27×
Q3 24
0.31×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FULT
FULT
HRMY
HRMY
Operating Cash FlowLast quarter
$126.2M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
$304.5M
$126.2M
Q3 25
$116.1M
$108.7M
Q2 25
$91.7M
$79.3M
Q1 25
$703.0K
$34.0M
Q4 24
$416.6M
$75.6M
Q3 24
$-22.0M
$70.5M
Q2 24
$157.8M
$42.6M
Free Cash Flow
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
$126.0M
Q3 25
$108.7M
Q2 25
$79.3M
Q1 25
$33.9M
Q4 24
$75.0M
Q3 24
$70.5M
Q2 24
$42.0M
FCF Margin
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
51.7%
Q3 25
45.4%
Q2 25
39.6%
Q1 25
18.3%
Q4 24
37.3%
Q3 24
37.9%
Q2 24
24.3%
Capex Intensity
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.0%
Q2 24
0.4%
Cash Conversion
FULT
FULT
HRMY
HRMY
Q1 26
Q4 25
3.08×
5.61×
Q3 25
1.16×
2.14×
Q2 25
0.92×
1.99×
Q1 25
0.01×
0.75×
Q4 24
6.07×
1.53×
Q3 24
-0.35×
1.53×
Q2 24
1.66×
3.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons